Revisiting the former approach: Low-dose dopamine in kidney transplant recipients
Objective: We aim to evaluate the effects of low-dose dopamine (LDD) infusion (0.5 – 2.5 g/kg/min) on hemodynamic status and short-term graft function in kidney transplant recipients. Materials and Methods: Patients who underwent kidney transplantation surgery between January 2007 and December 2016 were included in the study. Demographic and laboratory data, presence of delayed graft function, and the rates of rejection, graft loss, and mortality were recorded. The data were compared between patients with and without LDD treatment. Results: A total of 126 patients were included in the study (M/F:50.8%/49.2%; mean age, 38.94 ± 11.8 years). Ninety-four patients (74.6%) received living-donor transplants. Fifty-seven patients underwent LDD infusion in the postoperative period (LDD group), while 69 patients did not receive LDD infusion. Demographic and laboratory data of the patients did not significantly differ between groups. Nineteen patients in the LDD group experienced delayed graft function (p=0.039). However, these patients tended to be older, have a longer dialysis period prior to transplantation, deceased and hypertensive donors. There was no significant difference in renal function at 6 months after transplantation between groups. Conclusion: Although, LDD infusion increases kidney blood flow,
___
- Pollock DM, Arendshorst WJ. Tubuloglomerular feedback
and blood flow autoregulation during DA1-induced renal
vasodilation. Am J Physiol 1990;258(3 Pt 2):F627-35. doi:
10.1152/ajprenal.1990.258.3.F627
- Schenarts PJ, Sagraves SG, Bard MR, et al. Low-dose dopamine:
a physiologically based review. Curr Surg 2006;63:219-25. doi:
10.1016/j.cursur.2005.08.008
- Ciapetti M, di Valvasone S, di Filippo A, Cecchi A, Bonizzoli
M, Peris A. Low-dose dopamine in kidney transplantation.
Transplant Proc 2009;41:4165-8. doi: 10.1016/j.
transproceed.2009.08.058
- Hall J. Guyton and Hall Textbook of Medical Physiology. 13th
Edition, Philadelphia: W B Saunders, 2015.
- Dalton RS, Webber JN, Cameron C, et al. Physiologic impact
of low-dose dopamine on renal function in the early post
renal transplant period. Transplantation 2005;79:1561-7. doi:
10.1097/01.tp.000.015.8431.81676.c4
- Spicer ST, Gruenewald S, O’Connell PJ, Chapman JR, Nankivell
BJ. Low-dose dopamine after kidney transplantation:
assessment by Doppler ultrasound. Clin Transplant
1999;13:479-83. doi: 10.1034/j.1399-0012.1999.130607.x
- Stevens PE, Levin A. Evaluation and management of chronic
kidney disease: synopsis of the kidney disease: improving
global outcomes 2012 clinical practice guideline. Ann Intern
Med 2013;158:825-30. doi: 10.7326/0003-4819-158-11-
201306.040.00007
- Singh RP, Farney AC, Rogers J, et al. Kidney transplantation
from donation after cardiac death donors: lack of impact
of delayed graft function on post-transplant outcomes.
Clin Transplant 2011;25:255-64. doi: 10.1111/j.1399-
0012.2010.01241.x
- Johnston O, O’Kelly P, Spencer S, et al. Reduced graft function
(with or without dialysis) vs immediate graft function—a
comparison of long-term renal allograft survival. Nephrol
Dial Transplant 2006;21:2270-4. doi: 10.1093/ndt/gfl103
- Schwartz LB, Gewertz BL. The renal response to low dose
dopamine. J Surg Res. 1988;45:574-88. doi: 10.1016/0022-
4804(88)90147-3
- Yura T, Yuasa S, Fukunaga M, Badr KF, Matsuo H. Role for
Doppler ultrasound in the assessment of renal circulation:
effects of dopamine and dobutamine on renal hemodynamics
in humans. Nephron 1995;71:168-75. doi: 10.1159/000188707
- Carmellini M, Romagnoli J, Giulianotti PC, et al. Dopamine
lowers the incidence of delayed graft function in transplanted
kidney patients treated with cyclosporine A. Transplant Proc
1994;26:2626-9. doi: Accession Number:7940818
- Dönmez A, Karaaslan D, Sekerci S, Akpek E, Karakayali H,
Arslan G. The effects of diltiazem and dopamine on early
graft function in renal transplant recipients. Transplant Proc
1999;31:3305-6. doi: 10.1016/s0041-1345(99)00736-8
- Grundmann R, Kindler J, Meider G, Stöwe H, Sieberth
HG, Pichlmaier H. Dopamine treatment of human cadaver
kidney graft recipients: a prospectively randomized trial. Klin
Wochenschr 1982;60:193-7. doi: 10.1007/bf01715586
- Flancbaum L, Dick M, Choban PS, Dasta JP. Effects of lowdose
dopamine on urine output in oliguric, critically ill, renal
transplant patients. Clin Transplant 1998;12:256-9.
- Hosseinzadeh H, Golzari SE, Abravesh M, et al. Effect of low
dose dopamine on early graft function in living unrelated
kidney donors. Urol J 2012;9:389-96.
- Humar A, Johnson EM, Payne WD, et al. Effect of initial slow
graft function on renal allograft rejection and survival. Clin
Transplant 1997;11:623-7.
- Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC. A
risk prediction model for delayed graft function in the current
era of deceased donor renal transplantation. Am J Transplant
2010;10:2279-86. doi: 10.1111/j.1600-6143.2010.03179.x
- O’Hara JF, Jr. Low-dose “renal” dopamine. Anesthesiol
Clin North Am 2000;18:835-51, ix. doi: 10.1016/s0889-
8537(05)70197-8
- Schnuelle P, Schmitt WH, Weiss C, et al. Effects of
dopamine donor pretreatment on graft survival after kidney
transplantation: A randomized trial. Clin J Am Soc Nephrol
2017;12:493-501. doi: 10.2215/cjn.07600716